Altered States of Consciousness: 2026 Review of 25 Disciplines
TLDR
A 2026 preprint examines 25 different practices that induce altered states—from mindfulness to psychedelics—finding that MDMA‑assisted therapy for PTSD (67 % response) and psilocybin‑assisted depression treatment (60–70 % response) have the strongest evidence. Across all groups, the most common brain signature is modulation of the default mode network. The review does not claim that any of these approaches cure or treat mental‑health disorders.
Overview of the 2026 Review
Gallardo LM’s preprint (2026) compiles evidence from over 25 distinct disciplines, grouped into five clusters:
- Contemplative & Meditative Practices (yoga, hypnotherapy, qigong, Tibetan meditation, mindfulness)
- Breathwork & Somatic Practices (holotropic breathwork, pranayama, somatic experiencing, trauma‑release exercises, Wim Hof method)
- Plant‑Based & Psychedelic Practices (ayahuasca, psilocybin, MDMA, ketamine, ibogaine, peyote, cannabis)
- Ritual, Cultural & Energetic Practices (shamanic drumming, Sufi whirling, sound therapy, sweat lodge, lucid dreaming)
- Neurotechnology & Sensory Modulation (neurofeedback, TMS, tDCS, float therapy, VR therapy, EMDR).
The review also introduces transpersonal hypnotherapy—specifically Life Between Lives (LBL) and Past Life Regression (PLR)—as frameworks that deserve rigorous empirical scrutiny.
Key Findings by Discipline
Research / Outcome / Strength / Explain (ROSE)
| Practice | Outcome | Evidence Grade | Key Take‑away |
|---|---|---|---|
| MDMA‑Assisted Therapy for PTSD | 67 % response in Phase‑3 RCTs | A | Strong short‑term efficacy for chronic PTSD |
| Psilocybin Therapy for Treatment‑Resistant Depression | 60–70 % response in multiple RCTs | A | Robust evidence for depression when other treatments fail |
| EMDR | Trauma‑related symptom reduction | A | Endorsed by WHO and APA for diverse trauma populations |
| Mindfulness‑Based Interventions | Relapse prevention in depression; anxiety reduction | A | Supported by several meta‑analyses |
| Neurofeedback | ADHD and anxiety symptom improvement | A | Benefits confirmed in systematic reviews |
| LBL / PLR | Existential distress / grief | B (tentative) | Limited to uncontrolled case series and open trials |
What the data show
– The most robust evidence (grade A) centres on MDMA, psilocybin, EMDR, mindfulness, and neurofeedback.
– LBL and PLR remain preliminary; controlled trials are lacking.
– The preprint itself is a pre‑review and sample sizes vary across studies.
A Surprising Commonality
In more than 80 % of the studies examined, the dominant neural signature is a reconfiguration of the default mode network (DMN)—the brain system linked to self‑referential thought. This convergence suggests that diverse practices may share a core mechanism of accessing deeper layers of consciousness.
Neurobiological Mechanisms
Across all clusters, the following mechanisms appear repeatedly:
- Default Mode Network (DMN) Modulation – suppression or re‑configuration facilitates access to subconscious material.
- Autonomic Regulation – increased vagal tone and heart‑rate variability indicate improved autonomic balance.
- Neuroplasticity – upregulation of BDNF supports neural remodeling.
- Memory Reconsolidation – permits integration of new experiences.
- Interoceptive Predictive Coding – updates maladaptive bodily priors.
- Theta & Alpha Entrainment – brainwave patterns that open pathways to the subconscious.
- Ego Dissolution – self‑transcendence experiences associated with reduced self‑referential processing.
Clinical Evidence Snapshot
| Intervention | Condition | Study Type | Response Rate | Evidence Grade |
|---|---|---|---|---|
| MDMA‑Assisted Therapy | PTSD | Phase 3 RCT | 67 % | A |
| Psilocybin Therapy | Treatment‑Resistant Depression | Multiple RCTs | 60–70 % | A |
| EMDR | Trauma | Systematic Review | N/A | A |
| Mindfulness‑Based Interventions | Depression Relapse / Anxiety | Meta‑analyses | N/A | A |
| Neurofeedback | ADHD / Anxiety | Systematic Review | N/A | A |
| LBL / PLR | Existential Distress / Grief | Case series / Open trials | N/A | B (tentative) |
Note: “Response rate” refers to the proportion of participants meeting predefined remission criteria.
What It Does NOT Prove
- Cure or Treatment Claims – The review does not show that any modality cures or treats mental‑health disorders.
- Long‑Term Efficacy – No data on sustained outcomes beyond the study periods.
- Safety Profiles – The preprint does not provide comprehensive safety or adverse‑event analyses.
- Generalizability – Findings are based on specific study populations; broader applicability remains unverified.
- Transpersonal Hypnotherapy Efficacy – Evidence is preliminary; controlled trials are lacking.
Evidence at a Glance
| Evidence Grade | Risk Grade | Confidence (Plain English) |
|---|---|---|
| A | High | Very strong evidence for MDMA, psilocybin, EMDR, mindfulness, and neurofeedback; tentative for transpersonal hypnotherapy. |
Conclusion
Gallardo’s 2026 preprint offers a panoramic view of altered‑state practices, mapping shared neurobiological pathways and summarizing the strongest clinical evidence currently available. While the data highlight promising avenues—particularly psychedelic‑assisted therapies and established trauma interventions—researchers and practitioners should remain cautious, recognizing that none of these modalities are proven cures, and that transpersonal hypnotherapy still requires rigorous, peer‑reviewed trials.
What is transpersonal hypnotherapy?
Transpersonal hypnotherapy includes modalities like Life Between Lives (LBL) and Past Life Regression (PLR) that aim to access deeper layers of consciousness beyond the personal self. The review notes preliminary case‑series evidence suggesting benefits for existential distress, grief, and depression, but emphasizes the need for controlled studies.
How effective is MDMA‑assisted therapy for PTSD?
Phase‑3 randomized controlled trials reported a 67 % response rate in participants with chronic PTSD, indicating robust short‑term efficacy. Long‑term outcomes and safety data are still under investigation.
Are these practices safe?
The preprint does not provide detailed safety analyses. While some interventions (e.g., mindfulness) are generally considered low‑risk, others (e.g., psychedelic‑assisted therapy) require medical oversight and careful screening.
What does the default mode network do?
The DMN is a network of brain regions active during rest and self‑referential thought. Modulation of the DMN is a common neurobiological signature across many altered‑state practices, potentially facilitating access to subconscious material.
Is the review peer‑reviewed?
No. The article is a preprint posted on Preprints.org and has not yet undergone formal peer review.
- Meditation and Brain Function – Explore how mindfulness alters neural activity.
- Psychedelic Therapy Evidence – Dive deeper into clinical trials of psilocybin and MDMA.
- Neurofeedback for ADHD – Learn how brain‑wave training can support attention disorders.
- Transpersonal Hypnotherapy Explained – Understand the theoretical underpinnings of LBL and PLR.
- Default Mode Network Basics – Get a primer on this key brain network.
- Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks — Including Life Between Lives and Transpersonal Hypnotherapy (Gallardo LM, 2026, Preprints.org)
Educational Disclaimer
This article is for informational and educational purposes only. It is not
medical advice, mental health advice, diagnosis, treatment guidance, or a
recommendation to use any substance, supplement, therapy, or protocol.
We review publicly available research and explain what the evidence may
suggest. Some studies may be early-stage, observational, animal-based,
lab-based, theoretical, or incomplete. Always consult a qualified
professional before making health-related decisions.
If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.
Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.
